$SLXN
Silexion Therapeutics Corp
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Ramat Gan, Israel
SLXN chart
What traders are saying about $SLXN
Latest postsSilexion Therapeutics Corp news
- Silexion Therapeutics Corp Estimates – NASDAQ:SLXNW
TradingView ·
- Silexion Therapeutics (Nasdaq:SLXN) - Stock Analysis
Simply Wall Street ·
- Silexion Therapeutics Announces First Patient Successfully Dosed in Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Yahoo Finance ·
- Silexion Therapeutics Announces Exercise of Warrants
Yahoo Finance ·
- Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
Yahoo Finance ·
- Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
Yahoo Finance ·
- Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
Yahoo Finance ·
- Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers
Yahoo Finance ·
- Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
Yahoo Finance ·
- Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
Yahoo Finance ·
- Silexion Therapeutics to Attend BIO International Convention 2026
Yahoo Finance ·
Silexion Therapeutics Corp key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$11.9M | -$16.5M | -$5.1M |
| Diluted EPS | $89.61 | $3955.11 | $659.55 |
| Total assets (year end) | $7.2M | $2.9M | $5.3M |
| Cash and equivalents (year end) | $6.0M | $1.2M | $4.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Silexion Therapeutics Corp
- Ticker
- SLXN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Ramat Gan, Israel
- Incorporated in
- Cayman Islands
- Fiscal year end
- December 31
- SEC CIK
- 2022416
- Former names
- Biomotion Sciences
Frequently asked questions
What exchange is Silexion Therapeutics Corp listed on?
Silexion Therapeutics Corp trades on the Nasdaq under the ticker symbol SLXN.
What industry is Silexion Therapeutics Corp in?
Silexion Therapeutics Corp is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Silexion Therapeutics Corp headquartered?
Silexion Therapeutics Corp's business address on file with the SEC is in Ramat Gan, Israel.
When does Silexion Therapeutics Corp's fiscal year end?
Silexion Therapeutics Corp's fiscal year ends on December 31.